Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP549125.RAQ2a_82qgu3IRxzL4ZKhqBM8McryFcfVshA_MyZ3z1iM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549125.RAQ2a_82qgu3IRxzL4ZKhqBM8McryFcfVshA_MyZ3z1iM130_assertion type Assertion NP549125.RAQ2a_82qgu3IRxzL4ZKhqBM8McryFcfVshA_MyZ3z1iM130_head.
- NP549125.RAQ2a_82qgu3IRxzL4ZKhqBM8McryFcfVshA_MyZ3z1iM130_assertion description "[Interestingly, p120beta mRNAs were expressed predominantly in the normal prostate, androgen-responsive prostate cancers and an androgen-sensitive prostate cancer cell line, LNCaP, but weakly in recurrent cancers and the androgen-insensitive prostate cancer cell lines PC3 and DU145.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549125.RAQ2a_82qgu3IRxzL4ZKhqBM8McryFcfVshA_MyZ3z1iM130_provenance.
- NP549125.RAQ2a_82qgu3IRxzL4ZKhqBM8McryFcfVshA_MyZ3z1iM130_assertion evidence source_evidence_literature NP549125.RAQ2a_82qgu3IRxzL4ZKhqBM8McryFcfVshA_MyZ3z1iM130_provenance.
- NP549125.RAQ2a_82qgu3IRxzL4ZKhqBM8McryFcfVshA_MyZ3z1iM130_assertion SIO_000772 18560202 NP549125.RAQ2a_82qgu3IRxzL4ZKhqBM8McryFcfVshA_MyZ3z1iM130_provenance.
- NP549125.RAQ2a_82qgu3IRxzL4ZKhqBM8McryFcfVshA_MyZ3z1iM130_assertion wasDerivedFrom befree-20140225 NP549125.RAQ2a_82qgu3IRxzL4ZKhqBM8McryFcfVshA_MyZ3z1iM130_provenance.
- NP549125.RAQ2a_82qgu3IRxzL4ZKhqBM8McryFcfVshA_MyZ3z1iM130_assertion wasGeneratedBy ECO_0000203 NP549125.RAQ2a_82qgu3IRxzL4ZKhqBM8McryFcfVshA_MyZ3z1iM130_provenance.